Form 4: Arvinas CSO Sells Shares for Tax Obligations
Insider Transaction Report
Arvinas Chief Scientific Officer Angela M. Cacace sold shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Angela M. Cacace, Chief Scientific Officer of Arvinas, Inc. (ARVN), reported two sales of common stock on February 23, 2026.
- The first transaction involved the sale of 1,038 shares at a price of $12.16 per share.
- The second transaction involved the sale of 2,571 shares at a price of $12.16 per share.
- These sales were non-discretionary and automatically executed by the Issuer to cover tax withholding obligations.
- The sales were connected to the vesting and settlement of restricted stock units (RSUs) granted on February 22, 2023, and February 23, 2024.
- Following these transactions, Angela M. Cacace beneficially owns 147,623 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sales are non-discretionary and solely for tax purposes related to RSU vesting, which is a routine occurrence and does not signal any change in company fundamentals or management's confidence.
Positives
- The underlying vesting of restricted stock units (RSUs) represents a positive compensation event for the Chief Scientific Officer.
Negatives
- No direct negative implications for investors are indicated by these non-discretionary sales, as they are routine tax-related transactions.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
StockSavvy.ai notes that sales of shares by executives to cover tax withholding obligations upon the vesting of restricted stock units (RSUs) are a standard and common practice across all industries, particularly in biotechnology and pharmaceutical companies like Arvinas, where equity compensation is a significant component of executive pay.
Stakeholder Impact
- Minimal direct impact on shareholders as the transactions are non-discretionary sales for tax withholding purposes, a common practice in executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/22/2023 | Grant date for a portion of the restricted stock units (RSUs) that vested, leading to a tax-related sale. |
| 02/23/2024 | Grant date for a portion of the restricted stock units (RSUs) that vested, leading to a tax-related sale. |
| 02/23/2026 | Date of the reported common stock sales by Angela M. Cacace. |
| 02/25/2026 | Date the Form 4 was filed. |
Keywords
Arvinas, ARVN, Insider Trading, Form 4, Stock Sale, Tax Withholding, RSU Vesting, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.